CGRP is a 37-amino acid neuropeptide found in the central and peripher
al nervous systems as well as the nerve endings in lymphoid organs. Sp
ecific CGRP receptors are present on both T and B lymphocytes. There i
s increasing evidence that CGRP plays a role in regulation of the immu
ne response. However, few investigations have examined the effects of
CGRP on lymphocyte effector functions. In this report, CGRP (0.1 nM-1
mu M) was shown to cause concentration-dependent inhibition of IL-2-ac
tivated lymphocyte growth inhibition of the fungus Candida albicans an
d cytotoxic activity for tumor cells. Maximum inhibition of lymphocyte
activity by CGRP was 47.4% for the hyphae of C. albicans, 44.8% for a
natural killer cell susceptible cell line, and 52.9% for a natural ki
ller cell-resistant cell line. CGRP-mediated inhibition of lymphocyte
function was mimicked by 8-bromo-cAMP (1 mM) and was correlated in a c
oncentration-dependent manner with an increase in intracellular levels
of cAMP. These increases were potentiated by pretreatment of the lymp
hocytes with 3-isobutyl-1-methylxanthine (0.5 mM, 10 min), an inhibito
r of the cAMP phosphodiesterase. hCGRP(8-37), a selective blocker of t
he CGRP(1) receptor, abrogated the effect of CGRP on lymphocyte functi
on and on intracellular cAMP level elevation induced by rCGRP. CGRP ha
d no direct effect on the capacity of IL-2-activated lymphocytes to ad
here to the hyphae of C. albicans. However, both CGRP and 8-bromo-cAMP
diminished the capacity of the lymphocytes to release cytoplasmic gra
nular content when stimulated by the hyphae of C. albicans. These data
show that CGRP inhibits functional activity of IL-2-activated lymphoc
ytes and suggest that hCGRP(8-37) may be a useful tool for assessing t
he role of CGRP in the immune system. (C) 1995 Academic Press, Inc.